EyePoint, Inc.
EYPT · XNASCIK 1314102fmd_1Z34NYD0B83DGC3GA6BNVXJVNBManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jul 01, 2009 to Sep 30, 2026, 66 periods
| Line item | FY2017 | FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 8 | – | 5 | 20 | 34 | 37 | 41 | 46 | 43 | 31 |
| Research and development | 15 | – | 19 | 15 | 17 | 29 | 50 | 65 | 133 | 221 |
| Selling, general and administrative | 11 | – | 25 | 48 | 46 | 53 | 60 | 52 | 52 | 52 |
| Total operating expenses | 26 | – | 44 | 68 | 72 | 92 | 141 | 121 | 189 | 275 |
| Operating income | (19) | – | (39) | (48) | (37) | (55) | (100) | (75) | (146) | (243) |
| Interest expense | 0 | – | 2 | 6 | 7 | 5 | 3 | 1 | 0 | 0 |
| Interest and investment income | – | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | 0 | – | 0 | (9) | (8) | (3) | (3) | 4 | 15 | 12 |
| Income before taxes | (18) | (53) | – | (57) | (45) | (58) | (102) | (71) | (131) | (232) |
| Income tax expense | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (18) | (53) | – | (57) | (45) | (58) | (102) | (71) | (131) | (232) |
| Net income | (18) | (53) | – | (57) | (45) | (58) | (102) | (71) | (131) | (232) |